Response to interferon-α treatment correlates with recovery of blood plasmacytoid dendritic cells in children with chronic hepatitis B

Journal of Hepatology

Volumn 47, Issue 6, 2007, Pages 751-759

  Zhang, Zheng ^a   Zhang, Hongfei ^a   Chen, Dawei ^a   Yao, Jinxia ^a   Fu, Junliang ^a   Jin, Lei ^a   Wang, Fu Sheng ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

Antiviral therapy; Children; Dendritic cells; Hepatitis B virus; Interferon ; Plasmacytoid dendritic cells; Response

Indexed keywords

ALPHA1 INTERFERON;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; MALE; MONOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SEROCONVERSION; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; CELL COUNT; CHILD; CHILD, PRESCHOOL; CYTOKINES; DENDRITIC CELLS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; LONGITUDINAL STUDIES; MYELOID CELLS; TH1 CELLS; TREATMENT OUTCOME;

EID: 35748936151     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.07.019     Document Type: Article

References (33)

1. Guidotti L.G., and Chisari F.V. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol Mech Dis 1 (2006) 23-61
2. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
3. Webster G.J., Reignat S., Maini M.K., Whalley S.A., Ogg G.S., King A., et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32 (2000) 1117-1124
4. Maini M.K., Boni C., Lee C.K., Larrubia J.R., Reignat S., Ogg G.S., et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191 (2000) 1269-1280
5. Boni C., Penna A., Bertoletti A., Lamonaca V., Rapti I., Missale G., et al. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol 39 (2003) 595-605
6. van der Molen R.G., Sprengers D., Biesta P.J., Kusters J.G., and Janssen H.L.A. Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV. Hepatology 44 (2006) 907-914
7. Tang T.J., Kwekkeboom J., Mancham S., Binda R.S., de Man R.A., Schalm S.W., et al. Intrahepatic CD8 T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection. J Hepatol 43 (2005) 45-52
8. Rossol S., Marinos G., Carucci P., Singer M.V., Williams R., and Naoumov N.V. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 99 (1997) 3025-3033
9. Carotenuto P., van Riel D., Artsen A., Bruijns S., Uytdehaag F.G., Laman J.D., et al. Antiviral treatment with alpha Interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B. Antimicrob Agents Chemother 49 (2005) 590-599
10. Gregorek H., Dzierzanowska-Fangrat K., Woynarowski M., Jozwiak P., Witkowska-Vogtt E., Socha J., et al. Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-α therapy: correlation with specific IgG subclass responses to HBsAg. J Hepatol 42 (2005) 486-490
11. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
12. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23 (2005) 275-306
13. Kadowaki N., Antonenko S., Lau J.Y., and Liu Y.J. Natural interferon α/β-producing cells link innate and adaptive immunity. J Exp Med 192 (2000) 219-226
14. Fonteneau J.F., Gilliet M., Larsson M., Dasilva I., Munz C., Liu Y.J., et al. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 101 (2003) 3520-3526
15. Fonteneau J.F., Larsson M., Beignon A.S., McKenna K., Dasilva I., Amara A., et al. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 78 (2004) 5223-5232
16. Duan X.Z., Wang M., Li H.W., Zhuang H., Xu D., and Wang F.S. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 24 (2004) 637-646
17. Van der Molen R.G., Sprengers D., Binda R.S., de Jong E.C., Niesters H.G., Kusters J.G., et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40 (2004) 738-746
18. Zheng B.J., Zhou J., Qu D., Siu K.L., Lam T.W., Lo H.Y., et al. Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J Viral Hepatitis 11 (2004) 217-224
19. Zhang Z., Chen D., Yao J., Zhang H., Jin L., Shi M., et al. Increased infiltration of intrahepatic DC subsets closely correlates with viral control and serum aminotransferase in immune active pediatric patients with chronic hepatitis B. Clin Immunol 122 (2007) 173-180
20. Goutagny N., Vieux C., Decullier E., Ligeoix B., Epstein A., Trepo C., et al. Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection. J Infect Dis 189 (2004) 1646-1655
21. Kunitani H., Shimizu Y., Murata H., Higuchi K., and Watanabe A. Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. J Hepatol 36 (2002) 734-741
22. Salazar-Mather T.P., Lewis C.A., and Biron C.A. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1a delivery to the liver. J Clin Invest 110 (2002) 321-330
23. Zabel B.A., Silverio A.M., and Butcher E.C. Chemokine-like receptor 1 expression and chemerin directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol 174 (2005) 244-251
24. Piqueras B., Connolly J., Freitas H., Palucka A.K., and Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107 (2006) 2613-2618
25. Greenway A.L., Hertzog P.J., Devenish R.J., Dudley F.J., McMullen G.L., and Linnane A.W. Immunolocalisation of interferon-alpha in hepatitis C patients and its correlation with response to interferon-alpha therapy. J Hepatol 21 (1994) 842-852
26. Asselin-Paturel C., Brizard G., Chemin K., Boonstra A., O'Garra A., Vicari A., et al. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 201 (2005) 1157-1167
27. Abe M., Akbar S.M., Horiike N., and Onji M. Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol 34 (2001) 61-67
28. Wieland S.F., Guidotti L.G., and Chisari F.V. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol 74 (2000) 4165-4173
29. Robek M.D., Wieland S.F., and Chisari F.V. Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J Virol 76 (2002) 3570-3574
30. Guidotti L.G., Morris A., Mendez H., Koch R., Silverman R.H., Williams B.R., et al. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J Virol 76 (2002) 2617-2621
31. van Nunen A.B., Hansen B.E., Suh D.J., Löhr H.F., Chemello L., Fontaine H., et al. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase. Gut 52 (2003) 420-424
32. Derstrom A., Lindh M., Ekholm K., Conadi N., Horal P., Krantz M., et al. Predictive factors and virological response to interferon treatment in children with chronic hepatitis B. Scand J Infect Dis 37 (2005) 40-47
33. Liaw Y.F., and Sollano J.D. Factors influencing liver disease progression in chronic hepatitis B. Liver Int 26 (2006) 23-29